Semnur Pharmaceuticals, Inc. Accounts Payable and Other Accrued Liabilities, Current
Semnur Pharmaceuticals, Inc. (SMNR) had Accounts Payable and Other Accrued Liabilities, Current of $5.09 million as of 2025-06-30, per its 10-Q filed 2025-08-15.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2025-08-15
- 2025-06-30: Accounts Payable and Other Accrued Liabilities, Current $5.09M.
- 2025-03-31: Accounts Payable and Other Accrued Liabilities, Current $4.77M.
- 2024-12-31: Accounts Payable and Other Accrued Liabilities, Current $4.64M.
- 2024-09-30: Accounts Payable and Other Accrued Liabilities, Current $3.86M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2025-06-30 | $5.09M 10-Q · filed 2025-08-15 |
| 2025-03-31 | $4.77M 10-Q · filed 2025-05-16 |
| 2024-12-31 | $4.64M 10-Q · filed 2025-08-15 |
| 2024-09-30 | $3.86M 10-Q · filed 2024-11-19 |
| 2024-06-30 | $3.83M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $3.80M 10-Q · filed 2024-05-22 |
| 2023-12-31 | $3.75M 10-K · filed 2025-04-02 |
| 2023-09-30 | $3.74M 10-Q · filed 2023-11-09 |
| 2022-12-31 | $1.29M 10-K · filed 2024-04-01 |